US Stock MarketDetailed Quotes

Halozyme Therapeutics (HALO)

Watchlist
  • 63.960
  • +0.300+0.47%
Close May 1 16:00 ET
  • 63.694
  • -0.267-0.42%
Post 20:01 ET
7.58BMarket Cap24.98P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Halozyme Therapeutics (HALO) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Research, development and commercialization of our proprietary enzymes and devices, Hypercon1.4B100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States822.98M58.93%
Switzerland276.41M19.79%
Belgium217.52M15.57%
Japan46.37M3.32%
All Other Foreign33.33M2.39%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -